232 related articles for article (PubMed ID: 27145850)
1. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer.
Yu T; Lao X; Zheng H
Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850
[TBL] [Abstract][Full Text] [Related]
2. Alkaloids as Cyclooxygenase Inhibitors in Anticancer Drug Discovery.
Hashmi MA; Khan A; Farooq U; Khan S
Curr Protein Pept Sci; 2018; 19(3):292-301. PubMed ID: 28059042
[TBL] [Abstract][Full Text] [Related]
3. Anti-Inflammatory Drugs as Anticancer Agents.
Zappavigna S; Cossu AM; Grimaldi A; Bocchetti M; Ferraro GA; Nicoletti GF; Filosa R; Caraglia M
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283655
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed.
Liu R; Xu KP; Tan GS
Eur J Pharmacol; 2015 Dec; 769():127-33. PubMed ID: 26548623
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.
Kolawole OR; Kashfi K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163356
[TBL] [Abstract][Full Text] [Related]
6. Coumarins scaffolds as COX inhibitors.
Revankar HM; Bukhari SN; Kumar GB; Qin HL
Bioorg Chem; 2017 Apr; 71():146-159. PubMed ID: 28222891
[TBL] [Abstract][Full Text] [Related]
7. Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases.
Rayar AM; Lagarde N; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitia M
Curr Top Med Chem; 2017; 17(26):2935-2956. PubMed ID: 28828990
[TBL] [Abstract][Full Text] [Related]
8. Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick.
Suthar SK; Sharma M
Mini Rev Med Chem; 2016; 16(15):1201-1218. PubMed ID: 27121716
[TBL] [Abstract][Full Text] [Related]
9. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.
Khanapure SP; Garvey DS; Janero DR; Letts LG
Curr Top Med Chem; 2007; 7(3):311-40. PubMed ID: 17305573
[TBL] [Abstract][Full Text] [Related]
10. Novel functions of bovine milk-derived alpha-lactalbumin: anti-nociceptive and anti-inflammatory activity caused by inhibiting cyclooxygenase-2 and phospholipase A2.
Yamaguchi M; Yoshida K; Uchida M
Biol Pharm Bull; 2009 Mar; 32(3):366-71. PubMed ID: 19252279
[TBL] [Abstract][Full Text] [Related]
11. Rational Druggability Investigation Toward Selection of Lead Molecules: Impact of the Commonly Used Spices on Inflammatory Diseases.
Zakerali T; Shahbazi S
Assay Drug Dev Technol; 2018 Oct; 16(7):397-407. PubMed ID: 30106307
[TBL] [Abstract][Full Text] [Related]
12. Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1.
Jin S; Muhammad N; Sun Y; Tan Y; Yuan H; Song D; Guo Z; Wang X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23313-23321. PubMed ID: 32897000
[TBL] [Abstract][Full Text] [Related]
13. Exploiting cyclooxygenase-(in)dependent properties of COX-2 inhibitors for malignant glioma therapy.
Schönthal AH
Anticancer Agents Med Chem; 2010 Jul; 10(6):450-61. PubMed ID: 20879982
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and anti-tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model.
Hosseini F; Mahdian-Shakib A; Jadidi-Niaragh F; Enderami SE; Mohammadi H; Hemmatzadeh M; Mohammed HA; Anissian A; Kokhaei P; Mirshafiey A; Hassannia H
Biomed Pharmacother; 2018 Feb; 98():793-800. PubMed ID: 29571248
[TBL] [Abstract][Full Text] [Related]
15. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy.
Sarkar FH; Adsule S; Li Y; Padhye S
Mini Rev Med Chem; 2007 Jun; 7(6):599-608. PubMed ID: 17584158
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer.
Clària J; Romano M
Curr Pharm Des; 2005; 11(26):3431-47. PubMed ID: 16250846
[TBL] [Abstract][Full Text] [Related]
18. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
[TBL] [Abstract][Full Text] [Related]
19. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
20. Selective cyclooxygenase-2 (COX-2) inhibitors used for preventing or regressing cancer.
de Souza Pereira R
Recent Pat Anticancer Drug Discov; 2009 Jun; 4(2):157-63. PubMed ID: 19519538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
